Abstract:In the present prospective clinical trial, the effect of various regenerative procedures performed at sites with angular bone defects were evaluated. The main outcome variable was probing attachment alteration. Material and methods: 40 subjects, aged 32-61 years participated. They met the following inclusion criteria: (i) presence of generalized, advanced periodontal tissue destruction; (ii) presence of 2 similar, contralateral, angular bone defects (experimental sites) located in either the maxilla or the mandible; (iii) the defect site must exhibit a probing pocket depth (PPD) of > or = 6 mm, a probing attachment level (PAL) of > or = 7 mm, and a depth of the intrabony component of > or = 3 mm. All subjects had a good oral hygiene standard, were in good general health and did not use any medication. Prior to the start of the study, all subjects received non-surgical treatment for periodontal disease. Baseline clinical measurements (plaque, gingivitis, PPD, PAL and soft tissue recession) of the selected experimental sites were obtained 6 months after the completion of basic therapy. The 40 subjects were randomly divided into 4 treatment groups including 10 subjects each: 3 membrane groups and one Emdogain group. 1 h before surgery, the patients were given 3 g of Amoxicillin. No other antibiotics were prescribed. The test and control sites were treated during the same surgical session. Full thickness flaps were elevated and the exposed root surfaces were planed. Membrane placement: The root surface was rinsed with saline. A barrier membrane (Guidor or Resolut or Periodontal (e-PTFE) material) was positioned to cover the defect and the adjacent 2-3 mm of bone tissue. The control treatment was identical to the test treatment with the exception of barrier placement. Emdogain placement: The exposed root surfaces at both the test and control sites were, during a 2-min period, conditioned with a 24% EDTA gel. Emdogain was applied to the exposed root surface of the test site. In the control site, the vehicle, the PGA gel, was used as placebo control. The flaps were closed and sutured to obtain a complete coverage of the intrabony defect. Results: Re-examinations, which were performed 12 months after surgery, disclosed that regenerative therapy, including either the use of barrier membranes or application of enamel matrix proteins to an instrumented root surface in an angular, intrabony defect, enhanced outcome variables such as probing pocket depth and probing attachment gain. It was furthermore demonstrated that clinical improvements were better at sites with deep, than at sites with shallow, intrabony defects. Conclusion: The 4 regenerative modalities tested appeared to be equally effective in terms of PPD reduction and PAL gain, and superior to open flap curettage alone.

Ten-year results following treatment of intrabony defects with an enamel matrix protein derivative combined with either a natural bone mineral or a β-tricalcium phosphate

Five-year results evaluating the effects of platelet-rich plasma on the healing of intrabony defects treated with enamel matrix derivative and natural bone mineral

Four-year results following treatment of intrabony periodontal defects with an enamel matrix derivative alone or combined with a biphasic calcium phosphate

The use of enamel matrix derivative alone versus in combination with bone grafts to treat patients with periodontal intrabony defects: a meta-analysis.

Healing of two and three wall intrabony periodontal defects following treatment with an enamel matrix derivative combined with autogenous bone

Treatment of intrabony periodontal defects with enamel matrix derivative in private practice: a long-term retrospective study

Clinical outcomes after treatment of non-contained intrabony defects with enamel matrix derivative or guided tissue regeneration: a 12-month randomized controlled clinical trial

Enamel matrix proteins in the treatment of intra-bony defects. A prospective 24-month clinical trial

Enamel matrix derivative versus bioactive ceramic filler in the treatment of intrabony defects: 12-month results

Five-year follow-up of regenerative periodontal therapy with enamel matrix derivative at sites with angular bone defects

Long-term results of regenerative treatment of intrabony defects: a cohort study with 5-year follow-up

Treatment of periodontal defects with enamel matrix derivative: clinical evaluation at early healing stages

Effect of EDTA root conditioning on the healing of intrabony defects treated with an enamel matrix protein derivative

Clinical performance of a regenerative strategy for intrabony defects: scientific evidence and clinical experience

A 10‐Year Follow‐Up of Reconstructive Treatment of Peri‐Implantitis Using Mineralized Dehydrated Allograft and Resorbable Membrane: A Retrospective Case Series

Clinical evaluation of the regenerative potential of EMD and NanoHA in periodontal infrabony defects: a 2-year follow-up

Microsurgical access flap and enamel matrix derivative for the treatment of periodontal intrabony defects: a controlled clinical study

Periodontal regeneration with enamel matrix derivative in reconstructive periodontal therapy: a systematic review

The use of barrier membranes and enamel matrix proteins in the treatment of angular bone defects. A prospective controlled clinical study

Five years clinical results following treatment of human intra-bony defects with an enamel matrix derivative: a randomized controlled trial

Baseline radiographic defect angle of the intrabony defect as a prognostic indicator in regenerative periodontal surgery with enamel matrix derivative